Clinic study of prevention thrombus on paroxysmal atrial fibrillation patients with medium and high stroke risk

Clinic study of prevention thrombus on paroxysmal atrial fibrillation patients

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR-TRC-12002558

Enrollment

Unknown

Registered

2012-10-07

Start date

2011-07-04

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

paroxysmal atrial fibrillation patients

Interventions

group A:asprin 159mg/d

group B:wafarin low dose

group C:wafarin mediurn dose

GROUP D:wafarin high dose

GROUP E:medium rosk asprin 150mg qd

Eligibility

Sex/Gender

All

Age

65 Years to 78 Years

Inclusion criteria

Inclusion criteria: Elderly patients aged >=65 years with PAF were randomly assigned to aspirin or different intensities of warfarin for antithrombotic therapy. Subjects who met all of the inclusion criteria and none of the exclusion criteria would be recruited at each center

Exclusion criteria

Exclusion criteria: Reasons for exclusion were recorded by the clinicians for eligible patients not enrolled.

Contacts

Public ContactXin-Jun Chen

chenxinjunz@sina.com+86 13914175276

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026